PLATELETS AND VASCULAR THROMBOSIS

被引:35
作者
HARKER, LA
机构
关键词
D O I
10.1056/NEJM199404073301411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1006 / 1007
页数:2
相关论文
共 15 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[3]   PLATELETS AND THROMBOLYTIC THERAPY [J].
COLLER, BS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :33-42
[4]   A MURINE MONOCLONAL-ANTIBODY THAT COMPLETELY BLOCKS THE BINDING OF FIBRINOGEN TO PLATELETS PRODUCES A THROMBASTHENIC-LIKE STATE IN NORMAL PLATELETS AND BINDS TO GLYCOPROTEINS-IIB AND OR GLYCOPROTEIN-IIIA [J].
COLLER, BS ;
PEERSCHKE, EI ;
SCUDDER, LE ;
SULLIVAN, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (01) :325-338
[5]  
DALEN JE, 1992, CHEST, V102, pS303
[6]  
DAVIES MJ, 1994, HEMOSTASIS THROMBOSI, P1224
[7]   SAFETY AND ANTIPLATELET EFFECT OF MURINE MONOCLONAL-ANTIBODY 7E3 FAB DIRECTED AGAINST PLATELET GLYCOPROTEIN-IIB/IIIA IN PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOPLASTY [J].
ELLIS, SG ;
TCHENG, JE ;
NAVETTA, FI ;
MULLER, DWM ;
WEISMAN, HF ;
SMITH, C ;
ANDERSON, KM ;
CALIFF, RM ;
TOPOL, EJ .
CORONARY ARTERY DISEASE, 1993, 4 (02) :167-175
[8]  
FRELINGER AL, 1990, J BIOL CHEM, V265, P6346
[9]   EFFECTS OF MONOCLONAL-ANTIBODIES AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA COMPLEX ON THROMBOSIS AND HEMOSTASIS IN THE BABOON [J].
HANSON, SR ;
PARETI, FI ;
RUGGERI, ZM ;
MARZEC, UM ;
KUNICKI, TJ ;
MONTGOMERY, RR ;
ZIMMERMAN, TS ;
HARKER, LA .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (01) :149-158
[10]  
HARKER LA, 1994, HEMOSTASIS THROMBOSI, P1638